Rheumatoid arthritis is a chronic inflammatory joint disease characterized by the presence of autoantibodies. The best known autoantibody is the rheumatoid factor. Another group of antibodies directed against citrullinated epitopes is proven to be more specific for rheumatoid arthritis. This review gives an overview of the history of the different anti-citrullinated protein antibody detection methods and their diagnostic and prognostic properties in RA.
SmolenJ.S.. 1996. Rheumatoid arthritis. In manual of biologic markers of disease.MainiR.N., van VenrooijW.J., ed. Kluwer Academic PublishersDordrecht The Netherlands, p. C.1.1.
2.
ArnettF.C., EdworthyS.M., BlochD.A., Mc ShaneD.J., FriesJ.F., CooperN.S., HealeyL.A., KaplanS.R., LiangM.H., LuthraH.S.1988. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum.31: 315.
3.
SchellekensG.A., de JongB.A., van den HoogenFH., van de PutteL.B., and van VenrooijW.J.. 1998. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.J. Clin. Invest.101: 273.
4.
Girbal-NeuhauserE., DurieuxJ-J., ArnaudM., DalbonP., SebbagM., VincentC., SimonM., SenshuT., Masson-BessièreC., Jolivet-ReynaudC., JolivetM., and SerreG.. 1999. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.J. Immunol.162: 585.
5.
NienhuisR.L.F., and MandemaE.A.. 1964. A new serum factor in patients with rheumatoid arthritis.Ann. Rheum. Dis.23: 302.
6.
HoetR.M., BoerboomsA.M., ArendsM., RuiterD.J., and van VenrooijW.J.. 1991. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.Ann. Rheum. Dis.50: 611.
7.
HaakeA.R., and PolakowskaR.R.. Cell death by apoptosis in epidermal biology.1993. J. Invest. Dermatol.101:107.
8.
AsagaH., YamadaM., and SenshuT.. 1998. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages.Biochem. Biophys. Res. Comm.243: 641.
9.
UnionA., MeheusL., HumbelR., ConradK., SteinerG., MoereelsH., PottelH., SerreG., and De KeyserF.. 2002. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay.Arthritis Rheum.46: 1185.
10.
VincentC., NoguieraL., SebbagM., Chapuy RegaudS., ArnaudM., LetourneurO., RollandD., FournieB., CantagrelA., JolivetM., and SerreG.. 2002. Detection of antibodies to deiminated rat filaggrin by enzyme linked immunosorbent assay.Arthritis Rheum.46: 2051.
11.
GirbalE., SebbagV., Gomès-DaudrixV., SimonM., VincentC., and SerreG.. 1993. Characterisation of the rat esophagus epitelium antigens defined by the so-called “anti-keratin antibodies”, specific for rheumatoid arthritis.Ann. Rheum. Dis.52: 749.
12.
VincentC., SimonM., SebbagM., Girbal-NeuhauserE., DurieuxJ.J., CantagrelA., FourniéB., MazièresB., and SerreG.. 1998. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis.J. Rheumatol.25: 838.
13.
Gomes-DaudrixV., SebbagM., GirbalE., VincentC., SimonM., RakotoarivonyJ., AbbalM., FournieB., and SerreG.. 1994. Immunoblotting detection of so-called ‘antikeratin antibodies’: a new assay for the diagnosis of rheumatoid arthritis.Ann. Rheum. Dis.53: 735.
14.
PalosuoT., LukkaM., AleniusH., KalkkinenN., AhoK., KurkiP., HeikkiläR., NykänenM., and Von EssenR.. 1998. Purification of filaggrin from human epidermis and measurement of anti-filaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay.Int. Arch. Allergy. Immunol.115: 294.
15.
SchellekensG.A., VisserH., de JongB.A.W., van den HoogenF.H.J., HazesJ.M.W., BreedveldF.C., and van VenrooijW.J.. 2000. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.Arthritis Rheum.43: 155.
16.
NogueiraL., SebbagM., VincentC., ArnaudM., FournieB., CantagrelA., JolivetM., and SerreG.. 2001. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified of deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis.Ann. Rheum. Dis.60: 882.
17.
VossenaarE., van VenrooijW., and PruijnG.. 2002. Anti-CCP antibodies in early rheumatoid arthritis. In from proteomics to molecular epidemiology: relevance of autoantibodies.ConradK., FritzlerM., MeurerM., SackU., ShoenfeldY. ed. 6th Vol. 3 Dresden Symposium on autoantibodies. Autoantigens, autoantibodies, autoimmunity Dresden Germany, p.454.
18.
Masson-BessièreC., SebbagM., Girbal-NeuhauserE., NogueiraL., VincentC., SenshuT., and SerreG.. 2001. The major synovial targets of the Rheumatoid Arthritis-specific antifilaggrin autoantibodies are deiminated forms of the-and-chains of fibrin.J. Immunol.166: 4177.
19.
Masson-BessièreC., SebbagM., DurieuxJ-J., NogueiraL., VincentC., Girbal-NeuhauserV.E., DurrouxR., CantagrelA., and SerreG.. 2000. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum.Clin. Exp. Immunol.119: 544.
20.
NogueiraL., Chapuy RegaudS., ConstantinA., ClavelC., SebbagM., CantagrelA., VincentC., and SerreG.. 2003. Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis diagnosis.Arthritis Res. Therapy5(S):2.
21.
De RyckeL., PeeneI., HoffmanI.E.A., KruithofE., UnionA., MeheusL., VeysE.M., and De KeyserF.. 2004. Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.Ann. Rheum. Dis., (in press).
22.
AhoK., PalosuoT., LukkaM., KurkiP., IsomakiH., and Von EssenR.. 1999. Anti-filaggrin antibodies in recent onset arthritis.Scand. J. Rheumatol.28: 113.
23.
Goldbach-ManskyR., LeeJ., McCoyA., HoxworthJ., YarboroC., SmolenJ.S., SteinerG., RosenA., ZhangC., MénardH.A., ZhouZ.J., PalosuoT., van VenrooijW.J., WilderR.L., KlippelJ.H., SchumacherH.R.Jr., and El-GabalawyH.S.. 2000. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.Arthritis Res.2: 236.
24.
JansenA., Van der Horst-BruinsmaE., Van SchaardenburgD., Van de StadtR., De KoningM., and DijkmansB.. 2002. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.J. Rheumatol.29: 2074.
25.
ForslindK., VincentC., SerreG., and SvenssonB.. 2000. Antifilaggrin antibodies in early rheumatoid arthritis.Scand. J. Rheumatol.29: 320.
26.
KrootE.J., De JongB.A.W., Van LeeuwenM.A., SwinkelsH., Van den HoogenF.H.J., van t'hofM., Van de PutteL.B., Van RijswijkM.H., Van VenrooijW.J., and Van RielP.L.. 2000. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent onset rheumatoid arthritis.Arthritis Rheum.43: 1831.
27.
MeyerO., LabarreC., DougadosM., GoupilleP., CantagrelA., DuboisA., Nicaise-RolandP., SibiliaJ., and CombeB.. 2003. Anticitrullinated protein/peptide antibody assays in early rheumatoid arhtritis for predicting five year radiographic damage.Ann. Rheum. Dis.62: 120.
28.
PaimelaL., PalosuoT., AhoK., LukkaM., KurkiP., Leirisalo-RepoM., and Von EssenR.. 2001. Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis.Ann. Rheum. Dis.60: 32.
29.
Van JaarsveldC.H.M., ter BorgE.J., JacobsJ.W.G., SchellekensG.A., Gmelig-MeylingF.H.J., van Booma-FrankfortC., de JongB.A.W., van VenrooijW.J., and BijlsmaJ.W.J.. 1999. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis.Clin. Exp. Rheum.17: 689.
30.
VencovskyJ., MachacekS., SedovaL., KafkovaJ., GatterovaJ., PesakovaV., and RuzickovaS.. 2003. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.Ann. Rheum. Dis.62: 427.
31.
AhoK., PalosuoT., HeliovaaraM., KnektP., AlhaP., and von EssenR.. 2000. Antifilaggrin antibodies within normal range predict rheumatoid arthritis in a linear fashion.J. Rheumatol.27: 2743.
32.
Rantapää DahlqvistS., de JongB., HallmansG., WadellG., SundinU., and van VenrooijW.. 2002. Antibodies against citrullinated peptides (CCP) predict the development of rheumatoid arthritis.Arthritis Rheum.46: S200
33.
NielenM., van SchaardenburgD., van de StadtR., van der Horst-BruinsmaI., de KoningM., HabibuwM., ReesinkH., VandenbrouckeJ., and DijkmansB.. 2002. Autoantibodies in serum of blood donors precede symptoms of rheumatoid arthritis by I to 6 years.Arthritis Rheum.46: S370
34.
LipskyP.E., van der HeijdeD.M., St ClairE.W., FurstD.E., BreedveldF.C., KaldenJ.R., SmolenJ.S., WeismanM., EmeryP., FeldmannM., HarrimanG.R., and MainiR.N.. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group.N. Engl. J. Med.343: 1594.
35.
Munoz-FernandezS., Alvarez-DofornoR., Gonzalez-TarrioJ.M., BalsaA., RichiP., FontanG., Gijon-BanosJ., and Martin-MolaE.. 1999. Antiperinuclear factor as prognostic marker in rheumatoid arthritis.J. Rheumatol.26: 2572.
36.
KurkiP., von EssenR., KaarelaK., IsomakiH., PalosuoT., and AhoK.. 1997. Antibody to stratum corneum (antikeratin antibody) and antiperinuclear factor: markers for progressive rheumatoid arthritis.Scand. J. Rheumatol.26: 346.
37.
ForslindK., VincentC., SerreG., and SvenssonB.. 2001. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression.Scand. J. Rheumatol.30: 221.
38.
VisserH., le CessieS., VosK., BreedveldF., and HazesJ.. 2002. How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis.Arthritis Rheum.46: 357.
39.
BasS., PernegerT.V., MikhnevitchE., SeitzM., TiercyJ.M., Roux-LombardP., and GuerneP.A.. 2000. Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis.Rheumatology.39: 1082.
40.
BasS., PernegerT.V., SeitzM., TiercyJ.M., Roux-LombardP., and GuerneP.A.. 2002. Diagnostic test for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors.Rheumatology.41: 809.
41.
BasS., GenevayS., MeyerO., and GabayC.. 2003. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in diagnosis and prognosis of rheumatoid arthritis.Rheumatology.42: 677.
42.
VincentC., De KeyserF., Masson-BessièreC., SebbagM., VeysE.M., and SerreG.. 1999. Antiperinuclear factor compared with the so called antikeratin antibodies and antibodies to human epidermal filaggrin, in the diagnosis of arthritjdes.Ann. Rheum. Dis.58: 42.
43.
HillJ.A., SouthwoodS., SetteA., JevnikarA.M., BellD.A., and CairinsE.. 2003. Cutting Edge: the conversion of arginine to citrulline allows for a high affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.J. Immunol.171: 538.
44.
De RyckeL., Van DammeN., KruithofE., HoffmanE.I.A., Van den BoschF., VeysE.M., and De KeyserF.. 2002. The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies.Clin. Rheumatol.21: 446.
45.
SarauxA., BerthelotJ.M., ChalesG., Le HenaffC., MaryJ.Y., ThorelJ.B., HoangS., DueymesM., AllainJ., DevauchelleV., BaronD., Le GoffP., and YouinouP.. 2002. Value of laboratory tests in early prediction of rheumatoid arthritis.Arthritis Rheum.47: 155.
46.
BizarroN., MazzantiG., TonuttiE., VillaltaD., and TozolliR.. 2001. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.Clin. Chem.47: 1089.
47.
PalosuoT., TilvisR., StrandbergT., and AhoK.. 2003. Filaggrin related antibodies among the aged.Ann. Rheum. Dis.62: 261.
48.
BaetenD., PeeneI., UnionA., MeheusL., SebbagM., SerreG., VeysE.M., and De KeyserF.. 2001. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to anti-filaggrin autoantibodies.Arthritis Rheum.44: 2255.
49.
UtzP., GenslerT., and AndersonP.. 2000. Death, autoantigen modifications, and tolerance.Arthritis Res.2: 101.
50.
LeeD.M., and SchurP.H.. 2003. Clinical utility of the anti-CCP assay in patients with rheumatic diseases.Ann. Rheum. Dis.62: 870.
